Israeli company AISAP, has embarked on an international initiative to improve access to advanced medical diagnostics in Africa. AISAP’s technology has been deployed in clinics and hospitals across Ghana, enabling local physicians to perform accurate real-time cardiac ultrasound scans using artificial intelligence, even in remote areas with limited medical infrastructure. As part of the initiative, an AISAP delegation is conducting thousands of heart scans across multiple clinics and medical centers in Ghana, with the goal of early detection of common heart conditions such as heart failure and valve diseases, ensuring patients receive timely care.
The project is being carried out in partnership with the Global Alliance for Community Transformation (G-ACT) and with professional support from Sheba Medical Center and its innovation arm, ARC. The initiative is part of a broader international collaboration that includes U.S. medical and academic organizations and aims to bring one of the world’s most advanced medical technologies to underserved populations and healthcare peripheries in Africa. The program is expected to expand to additional African regions in 2026 and will serve as a foundation for large-scale research on the application of AI in diagnosing cardiovascular diseases in developing populations, in collaboration with medical institutions and international foundations.
AISAP’s system, approved by the U.S. FDA, provides automated, AI-driven diagnostics from portable ultrasound devices, transforming modern medicine. The technology allows physicians and healthcare workers in the field to receive immediate and precise interpretations of scans without requiring a cardiology specialist or dependence on large medical centers.
Access to healthcare in Ghana, as in much of sub-Saharan Africa, remains limited, particularly in rural and underserved areas. Many communities face shortages of trained medical personnel, insufficient diagnostic equipment, and long travel distances to reach hospitals or specialist clinics. As a result, early detection and timely treatment of chronic conditions such as heart disease are often delayed, contributing to high rates of preventable complications and mortality. Initiatives like AISAP’s AI-powered cardiac diagnostics aim to bridge these gaps, bringing advanced medical care directly to populations that otherwise have limited access.
“This project represents the heart of our mission, ensuring that access to advanced cardiac care should not depend on geographic location,” said Adiel Am-Shalom, CEO of AISAP. “We are deploying the same FDA-cleared technology trusted by major US hospitals across remote frontlines in Ghana. The model is clear – our cloud-based platform delivers specialist-grade insights to frontline physicians. This deployment is the ultimate proof of concept that AISAP can help solve the diagnostic gap for U.S. rural hospitals facing critical cardiologist shortages.”